ARK Invest bought 43,091 Meta Platforms shares through ARKK and ARKW on Wednesday, investing approximately $28.1 million based on Meta’s $653.69 closing price. ARKK purchased 38,304 shares and ARKW added 4,787. The firm also sold 72,803 Alphabet Class A shares from ARKK and 11,589 from ARKW, worth about $27.9 million at Alphabet’s $330.65 close. The trades came as Meta advances its Muse AI agent and benefits from a recent lawsuit settlement, while Alphabet faces investor concerns about AI spending and cloud growth. ARK also bought shares of Beam Therapeutics, CRISPR Therapeutics and Intellia Therapeutics, and sold Tempus AI shares.